Pharmacological therapy of asthma during pregnancy

Pharmacological therapy of asthma during pregnancy

Global summit on TUBERCULOSIS AND LUNG DISEASE
September 20-21, 2017 | Philadelphia, USA

Iram A

National University Hospital Rigshospitalet Glostrup, Denmark

Scientific Tracks Abstracts : Int J Respir Med

Abstract:

Asthma is one of the most frequent chronic diseases that complicate pregnancy. Well-controlled asthma during pregnancy reduces the risk for an exacerbation during pregnancy. Pharmacological asthma therapy in pregnant women is a challenge due to suboptimal adherence with controller therapy, pregnant women’s and professional health care’s concerns about harmful effects of medication on the fetus. These aspects make it necessary to evaluate the harmful effects of pharmacological asthma therapy and poor asthma control during pregnancy. The aim for my presentation is to provide an update on safety of asthma medication during pregnancy, based on recent clinical studies and International Guidelines.

Biography:

Iram A has completed her Master’s degree from Copenhagen University, Denmark. She is a Resident and Researcher with asthma among pregnant women as field of interest. She has published one article and is going to publish her second article.

PDF HTML